Paratek Pharmaceuticals’ Shares Gain Following FDA Fast Track Designation For Nontuberculous Mycobacterial (NTM) Drug - Benzinga
Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) received Fast Track designation from the U.S.
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: firstname.lastname@example.org